Option Care Health, Inc. $OPCH Shares Acquired by Bridges Investment Management Inc.

Bridges Investment Management Inc. grew its position in Option Care Health, Inc. (NASDAQ:OPCH) by 15.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 56,595 shares of the company’s stock after buying an additional 7,564 shares during the quarter. Bridges Investment Management Inc.’s holdings in Option Care Health were worth $1,838,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of OPCH. Farther Finance Advisors LLC grew its stake in shares of Option Care Health by 434.8% in the first quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company’s stock valued at $67,000 after buying an additional 1,561 shares in the last quarter. GAMMA Investing LLC grew its stake in Option Care Health by 307.1% during the 1st quarter. GAMMA Investing LLC now owns 3,192 shares of the company’s stock worth $112,000 after purchasing an additional 2,408 shares in the last quarter. SG Americas Securities LLC acquired a new position in Option Care Health during the 1st quarter worth $743,000. Wealth Enhancement Advisory Services LLC grew its stake in Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company’s stock worth $289,000 after purchasing an additional 1,691 shares in the last quarter. Finally, State of Alaska Department of Revenue grew its stake in Option Care Health by 2.7% during the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company’s stock worth $696,000 after purchasing an additional 525 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Norman L. Wright bought 3,411 shares of Option Care Health stock in a transaction dated Tuesday, September 9th. The stock was acquired at an average cost of $29.31 per share, with a total value of $99,976.41. Following the acquisition, the director owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Timothy P. Sullivan bought 20,000 shares of Option Care Health stock in a transaction dated Thursday, August 21st. The stock was purchased at an average cost of $27.51 per share, with a total value of $550,200.00. Following the completion of the acquisition, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders bought 59,411 shares of company stock valued at $1,627,576. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Down 0.1%

Shares of NASDAQ OPCH opened at $27.10 on Friday. The company has a market capitalization of $4.40 billion, a price-to-earnings ratio of 21.68, a price-to-earnings-growth ratio of 1.65 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The business has a 50-day moving average of $28.02 and a two-hundred day moving average of $30.35. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.Option Care Health’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently commented on OPCH. Weiss Ratings reissued a “hold (c)” rating on shares of Option Care Health in a research note on Wednesday, October 8th. JMP Securities boosted their target price on Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research note on Thursday, July 31st. Barrington Research reissued an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research note on Tuesday, September 23rd. TD Cowen began coverage on Option Care Health in a research note on Thursday, October 2nd. They set a “hold” rating and a $30.00 target price for the company. Finally, Cowen initiated coverage on Option Care Health in a research note on Thursday, October 2nd. They set a “hold” rating for the company. Eight investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $35.11.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.